A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff.
The portion of our nervous systems responsible for the "fight or flight" response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia ...
Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...
“C. diff is a really challenging pathogen,” said lead author Joseph Zackular, assistant professor of pathology and laboratory medicine at Penn. “This vaccine is kind of a really nice proof of ...
The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.
The portion of our nervous systems responsible for the "fight or flight" response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia ...
But in C. difficile cases, the nervous system can have a hyperactive response that becomes part of the problem, and UVA's new research explains why. Related Stories ...